Tolerance and Utilization of Polydextrose, Inulin, and Nutriose as Supplemental Fiber
This study aims to investigate how well your body tolerates and utilizes different types of supplemental fiber, specifically Polydextrose, Inulin, and Nutriose, by analyzing the bacteria present in your fecal samples and the products produced when these fibers are broken down.
polydextrose
+ soluble corn fiber
Basic Science Study
Summary
Study start date: July 1, 2010
Actual date on which the first participant was enrolled.This study focuses on the benefits of soluble fibers, specifically polydextrose, inulin, and nutriose, in maintaining gut health. These fibers are known to promote laxation and overall gastrointestinal health. The study aims to understand how these fibers affect protein and carbohydrate fermentation in the gut, potentially leading to a healthier microbial profile. By exploring the effects of nutriose and polydextrose as supplemental fibers in a human diet, researchers hope to uncover their potential in improving gut health and their application in the food industry. During the study, participants will receive polydextrose, inulin, and nutriose as supplemental fibers to their existing diet. The primary goal is to assess the tolerance of these fibers. Additionally, the study aims to understand how effectively the body utilizes polydextrose and nutriose. Participants will collect fecal samples during days 16-21 of each treatment period using provided materials. These samples will be analyzed for bacterial species and fermentation end products, providing insights into gut health and fiber utilization.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.25 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Male
Biological sex of participants that are eligible to enroll.From 20 to 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
33.333% chance of being blinded to the placebo group
Treatment Groups
Group I
PlaceboGroup II
ExperimentalGroup III
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives